A Missouri state jury on Tuesday found Boston Scientific and C.R. Bard not liable in a woman's $28 million suit alleging the companies' pelvic mesh implants rendered her incontinent and suffering from pain and other ailments.
Bard attorney Lori Cohen of Greenberg Traurig LLP said that the company fully complied with FDA standards, and that its device remains the "gold standard" treatment for stress urinary incontinence. The device worked and benefited the patient until a doctor needlessly removed the Align and caused more damage, she said.
She also added that Sherrer had other pelvic floor surgeries dating back to 1997. More surgeries mean more scarring and potential for problems, Cohen said.
Continue Reading via Media Link.